* Tabula Rasa HealthCare Inc TRHC.OQ TRHC.O is expected
to show a rise in quarterly revenue when it reports results on
August 5.
* The Moorestown, New Jersey-based company is expected to report
a 6.3% increase in revenue to $81.682 million from $76.83
million a year ago, according to the mean estimate from 9
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Tabula Rasa HealthCare
Inc is for breakeven results per share. For the same quarter
last year, the company reported earnings of 7 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Tabula Rasa
HealthCare Inc is $50, about 15.8% above its last closing
price of $42.09.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Mar. 31 2021 -0.09 -0.09 -0.09 Met 2.4
Dec. 31 2020 -0.10 -0.10 -0.08 Beat 17.2
Sep. 30 2020 0.05 0.04 -0.01 Missed -123.9
Jun. 30 2020 0.08 0.06 0.07 Beat 25.4
Mar. -0.03 -0.05 0.01 Beat 120.8
31 2020
Dec. 31 2019 0.04 0.04 0.13 Beat 251.4
Sep. 30 2019 0.18 0.17 0.22 Beat 29.3
Jun. 30 2019 0.08 0.06 0.35 Beat 480.4
This summary was machine generated August 4 at 00:05 GMT. All
figures in US dollars unless otherwise stated